Evidence map›Paper›PMID 39298333›Full record

ArticleeLife2024

Mutant mice lacking alternatively spliced p53 isoforms unveil

Anne Fajac, Iva Simeonova, Julia Leemput, Marc Gabriel, Aurélie Morin, Vincent Lejour, Annaïg Hamon, Jeanne Rakotopare, Wilhelm Vaysse-Zinkhöfer, Eliana Eldawra and 5 more

Abstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Anne FajacGenetics of Tumor Suppression, Institut Curie, Paris, France.
Iva SimeonovaGenetics of Tumor Suppression, Institut Curie, Paris, France.
Julia LeemputGenetics of Tumor Suppression, Institut Curie, Paris, France.
Marc GabrielCNRS UMR3244, Paris, France.
Aurélie MorinGenetics of Tumor Suppression, Institut Curie, Paris, France.
Vincent LejourGenetics of Tumor Suppression, Institut Curie, Paris, France.ORCID https://orcid.org/0000-0002-2797-1507
Annaïg HamonGenetics of Tumor Suppression, Institut Curie, Paris, France.
Jeanne RakotopareGenetics of Tumor Suppression, Institut Curie, Paris, France.
Wilhelm Vaysse-ZinkhöferGenetics of Tumor Suppression, Institut Curie, Paris, France.
Eliana EldawraGenetics of Tumor Suppression, Institut Curie, Paris, France.
Marina PinskayaCNRS UMR3244, Paris, France.
Antonin MorillonCNRS UMR3244, Paris, France.ORCID https://orcid.org/0000-0002-0575-5264
Jean-Christophe BourdonSchool of Medicine, Ninewells Hospital, University of Dundee, Dundee, United Kingdom.ORCID https://orcid.org/0000-0003-4623-9386
Boris BardotGenetics of Tumor Suppression, Institut Curie, Paris, France.ORCID https://orcid.org/0000-0003-4976-9593
Franck ToledoGenetics of Tumor Suppression, Institut Curie, Paris, France.ORCID https://orcid.org/0000-0003-3798-4106

Funding

European Research Council 875532-Prostator-ERC-2019-PoCFondation de France Comité tumeursLigue Contre le Cancer Comité Ile de FranceLigue Contre le Cancer Labellisation
6 · The paper itself

Abstract

The

Indexed as

Alternative SplicingProtein IsoformsTumor Suppressor Protein p53AnimalsFemaleHumansLymphoma, B-CellMaleMicePrognosisProto-Oncogene Proteins c-mycSex FactorsProtein IsoformsProto-Oncogene Proteins c-mycTrp53 protein, mouseTumor Suppressor Protein p53Ackr4Burkitt lymphomacancer biologyCcl21humanmouseMycp53sex disparity in cancer

Identifiers

PMID39298333
PMCPMC11412721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.